LARYNGEAL CANCER METASTATIC

This adverse event was reported 21 times

LARYNGEAL CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VORINOSTAT 1 0.0005
1 MELPHALAN HYDROCHLORIDE 6 0.0002
2 IXAZOMIB 6 0.0002
3 RALTEGRAVIR 1 0.0002
4 THALIDOMIDE 6 0.0002
5 LORLATINIB 1 0.0001
6 ATAZANAVIR 1 0.0001
7 BORTEZOMIB 6 0.0001
8 PANITUMUMAB 1 0.0001
9 IFOSFAMIDE FOR INJECTION 1 0.0000
See all drugs enriched for association with LARYNGEAL CANCER METASTATIC